Proscia Company

Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.
Technology: Artificial Intelligence, Biotechnology, Medical, Software
Industry: Clinical Development
Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 2014-07-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 10
Total Funding: 33973000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-11-30
Last Funding Type: Series B

Visit Website
info@proscia.com
http://twitter.com/ProsciaInc
Register and Claim Ownership